Sanofi Sarclisa combo gets Japanese nod for newly diagnosed multiple myeloma Ruchika Sharma27 Feb 2025 11:30 AM ISTParis: Sanofi has announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan has approved Sarclisa, in combination with...
Former FDA director Patrizia Cavazzoni rejoins Pfizer Ruchika Sharma25 Feb 2025 1:30 PM ISTNew York: Pfizer Inc. has announced that Patrizia Cavazzoni, M.D. will rejoin the company as Chief Medical Officer, Executive Vice President.In...
Sanofi nears selling 50 percent controlling stake in Opella to CD&R Ruchika Sharma21 Feb 2025 6:16 PM ISTParis: Sanofi and CD&R have announced that they have signed the share purchase agreement in relation to the sale of a 50 percent controlling...
USFDA grants priority review to Sanofi-Regeneron Dupixent for bullous pemphigoid Ruchika Sharma20 Feb 2025 12:30 PM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has accepted for priority review the supplemental biologics license...
Sanofi's Merilog Receives USFDA Approval as Biosimilar to Novolog for Diabetes Management Farhat Nasim17 Feb 2025 7:56 PM ISTNew Delhi: Sanofi has received U.S. Food and Drug Administration (FDA) approval for Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin...
Johnson & Johnson Halts Late-Stage Trial of ExPEC9V Vaccine for Sepsis, Blood Infections Farhat Nasim17 Feb 2025 7:01 PM ISTNo safety signals related to the experimental vaccine were identified, J&J said.
Sanofi acquires 2.3% of its shares from long-standing shareholder L'Oréal Ruchika Sharma4 Feb 2025 1:06 PM ISTParis: Sanofi has announced the acquisition of 2.3% of its shares from long-standing shareholder L’Oréal. This transaction is part of Sanofi’s...
Sanofi Sarclisa approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant Ruchika Sharma2 Feb 2025 10:45 AM ISTParis: Sanofi has announced that the National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a...
Sanofi Sarclisa approved in EU for newly diagnosed multiple myeloma Ruchika Sharma26 Jan 2025 1:30 PM ISTParis: Following the adoption of a positive opinion by the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use...
Sanofi Healthcare India gets CDSCO Panel nod to study Nirsevimab Dr. Divya Colin22 Jan 2025 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to the drug...
Sanofi Sarclisa gains Chinese nod for treatment of adult patients with relapsed or refractory multiple myeloma Ruchika Sharma14 Jan 2025 1:30 PM ISTParis: Sanofi has announced that the National Medical Products Administration (NMPA) in China has approved Sarclisa, an anti-CD38 medicine,...
CDSCO panel approves Sanofi's proposal to increase number of subjects from 25 to 40 in india to study SAR443122 Dr. Divya Colin5 Jan 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to the drug...
